Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1998-10-6
|
pubmed:abstractText |
The chemokine receptors CXCR4 and CCR5 have been identified as major coreceptors for HIV-1 entry into CD4+ T cells. The majority of primary HIV-1 isolates in early disease use CCR5 as a coreceptor, whereas during disease progression with the emergence of syncytium-inducing viruses, CXCR4 is also used. We performed a cross-sectional study in which we evaluated the expression of two HIV-1 coreceptors, CCR5 and CXCR4, in whole blood samples taken from HIV-1-infected and uninfected individuals. We demonstrate that CXCR4 on CD4+ and CD8+ T cells, and CD14+ monocytes is significantly down-regulated, and CCR5 expression on CD4+ T cells is up-regulated in HIV-infected individuals compared with uninfected controls. Coreceptor expression correlated with the level of cellular activation in vivo in both HIV-infected and uninfected individuals, with CXCR4 being expressed predominantly on quiescent (HLA-DR-) T cells and CCR5 being expressed predominantly on activated (HLA-DR+) T cells. Lower expression of CXCR4 and higher expression of CCR5 on CD4+ T cells correlated with advancing disease. In addition, a tendency for greater activation of CXCR4+CD4+ T cells in patients with advanced disease was observed. Patients who harbored syncytium-inducing viruses, however, could not be distinguished from those who harbored nonsyncytium-inducing viruses based on the level of CD4+ T cell activation or chemokine receptor expression.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
161
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3195-201
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9743388-HIV Infections,
pubmed-meshheading:9743388-HIV Seronegativity,
pubmed-meshheading:9743388-HIV Seropositivity,
pubmed-meshheading:9743388-HIV-1,
pubmed-meshheading:9743388-Humans,
pubmed-meshheading:9743388-Leukocytes,
pubmed-meshheading:9743388-Lymphocyte Activation,
pubmed-meshheading:9743388-Male,
pubmed-meshheading:9743388-Middle Aged,
pubmed-meshheading:9743388-Phenotype,
pubmed-meshheading:9743388-Receptors, CCR5,
pubmed-meshheading:9743388-Receptors, CXCR4,
pubmed-meshheading:9743388-T-Lymphocytes
|
pubmed:year |
1998
|
pubmed:articleTitle |
Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals.
|
pubmed:affiliation |
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892-1576, USA. mostrowski@nih.gov
|
pubmed:publicationType |
Journal Article
|